Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa

Journal of Applied Microbiology

Volumn 109, Issue 4, 2010, Pages 1311-1318

  Xu, G ^a,b   Xiong, W ^a   Hu, Q ^a   Zuo, P ^a   Shao, B ^a   Lan, F ^a   Lu, X ^a   Xu, Y ^a   Xiong, S ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

biofilm formation; lactoferricin; lactoferricin chimera; Pseudomonas aeruginosa; virulence factor

Indexed keywords

AMINO ACIDS; BACTERIA; BIOFILMS;

AMINO-ACIDS; BIOFILM FORMATION; LACTOFERRAMPIN; LACTOFERRICIN; LACTOFERRICIN CHIMERA; LACTOFERRIN; P.AERUGINOSA; PSEUDOMONAS AERUGINOSA; VIRULENCE FACTORS;

PEPTIDES;

ANTIINFECTIVE AGENT; ELASTASE; LACTOFERRAMPIN; LACTOFERRICIN; LACTOFERRIN; PEPSIN A; PEPTIDE; PYOCYANINE; UNCLASSIFIED DRUG;

AMINO ACID; ANTIMICROBIAL ACTIVITY; ASSAY; BACTERIUM; BIOACTIVITY; BIOFILM; CONCENTRATION (COMPOSITION); ENZYME ACTIVITY; INHIBITION; MICROBIAL ACTIVITY; PEPTIDE; PROTEIN; VIRULENCE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BIOFILM; CELL ASSAY; CELL VIABILITY; CHIMERA; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; DRUG ISOLATION; ENZYME ACTIVITY; NONHUMAN; PROTEIN ISOLATION; PSEUDOMONAS AERUGINOSA; STATISTICAL SIGNIFICANCE;

PSEUDOMONAS AERUGINOSA;

EID: 77956902854     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2010.04751.x     Document Type: Article

References (33)

1. Beatson, S.A., Whitchurch, C.B., Sargent, J.L., Levesque, R.C. Mattick, J.S. (2002) Differential regulation of twitching motility and elastase production by Vfr in Pseudomonas aeruginosa. J Bacteriol 184, 3605 3613.
2. Bellamy, W., Takase, M., Wakabayashi, H., Kawase, K. Tomita, M. (1992a) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73, 472 479.
3. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K. Tomita, M. (1992b) Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121, 130 136.
4. Berlutti, F., Ajello, M., Bosso, P., Morea, C., Petrucca, A., Antonini, G. Valenti, P. (2004) Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals 17, 271 278.
5. Berthelot, P., Grattard, F., Mahul, P., Pain, P., Jospe, R., Venet, C., Carricajo, A., Aubert, G. et al. (2001) Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med 27, 503 512.
6. Bolscher, J.G., Adao, R., Nazmi, K., van den Keybus, P.A., van 't Hof, W., Nieuw Amerongen, A.V., Bastos, M. Veerman, E.C. (2009) Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. Biochimie 91, 123 132.
7. Colwell, R.R. (2000) Viable but nonculturable bacteria: a survival strategy. J Infect Chemother 6, 121 125.
8. De Vos, D., Lim, A. Jr., Pirnay, J.P., Duinslaeger, L., Revets, H., Vanderkelen, A., Hamers, R. Cornelis, P. (1997) Analysis of epidemic Pseudomonas aeruginosa isolates by isoelectric focusing of pyoverdine and RAPD-PCR: modern tools for an integrated anti-nosocomial infection strategy in burn wound centres. Burns 23, 379 386.
9. Defez, C., Fabbro-Peray, P., Bouziges, N., Gouby, A., Mahamat, A., Daures, J.P. Sotto, A. (2004) Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect 57, 209 216.
10. Dietrich, L.E., Price-Whelan, A., Petersen, A., Whiteley, M. Newman, D.K. (2006) The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosa. Mol Microbiol 61, 1308 1321.
11. Eckhart, L., Fischer, H., Barken, K.B., Tolker-Nielsen, T. Tschachler, E. (2007) DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. Br J Dermatol 156, 1342 1345.
12. Essar, D.W., Eberly, L., Hadero, A. Crawford, I.P. (1990) Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol 172, 884 900.
13. Gambello, M.J. Iglewski, B.H. (1991) Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 173, 3000 3009.
14. Haney, E.F., Lau, F. Vogel, H.J. (2007) Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin. Biochim Biophys Acta 1768, 2355 2364.
15. Haukland, H.H., Ulvatne, H., Sandvik, K. Vorland, L.H. (2001) The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett 508, 389 393.
16. Hsueh, P.R., Tseng, S.P., Teng, L.J. Ho, S.W. (2005) Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect 11, 670 673.
17. van der Kraan, M.I., Groenink, J., Nazmi, K., Veerman, E.C., Bolscher, J.G. Nieuw Amerongen, A.V. (2004) Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25, 177 183.
18. Kuwata, H., Yip, T.T., Tomita, M. Hutchens, T.W. (1998a) Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim Biophys Acta 1429, 129 141.
19. Kuwata, H., Yip, T.T., Yip, C.L., Tomita, M. Hutchens, T.W. (1998b) Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun 245, 764 773.
20. Lau, G.W., Hassett, D.J., Ran, H. Kong, F. (2004) The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 10, 599 606. (Pubitemid 39573151)
21. Leon-Sicairos, N., Lopez-Soto, F., Reyes-Lopez, M., Godinez-Vargas, D., Ordaz-Pichardo, C. de la Garza, M. (2006) Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme. Clin Med Res 4, 106 113.
22. Leon-Sicairos, N., Canizalez-Roman, A., de la Garza, M., Reyes-Lopez, M., Zazueta-Beltran, J., Nazmi, K., Gomez-Gil, B. Bolscher, J.G. (2009) Bactericidal effect of lactoferrin and lactoferrin chimera against halophilic Vibrio parahaemolyticus. Biochimie 91, 133 140.
23. Marra, A.R., Bar, K., Bearman, G.M., Wenzel, R.P. Edmond, M.B. (2006) Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. J Infect 53, 30 35. (Pubitemid 43960436)
24. Merritt, J.H., Kadouri, D.E. O'Toole, G.A. (2005) Growing and analyzing static biofilms. Curr Protoc Microbiol 1, 1 17. Chapter 1, Unit 1B 1.
25. Munoz, A. Marcos, J.F. (2006) Activity and mode of action against fungal phytopathogens of bovine lactoferricin-derived peptides. J Appl Microbiol 101, 1199 1207.
26. Oliver, J.D. (2009) Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol Rev doi:.
27. Orsi, N. (2004) The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17, 189 196.
28. Prithiviraj, B., Bais, H.P., Weir, T., Suresh, B., Najarro, E.H., Dayakar, B.V., Schweizer, H.P. Vivanco, J.M. (2005) Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans. Infect Immun 73, 5319 5328.
29. Ran, H., Hassett, D.J. Lau, G.W. (2003) Human targets of Pseudomonas aeruginosa pyocyanin. Proc Natl Acad Sci USA 100, 14315 14320.
30. Singh, P.K. (2004) Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. Biometals 17, 267 270.
31. Smith, K.M., Bu, Y. Suga, H. (2003) Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem Biol 10, 81 89.
32. Takenaka, S., Iwaku, M. Hoshino, E. (2001) Artificial Pseudomonas aeruginosa biofilms and confocal laser scanning microscopic analysis. J Infect Chemother 7, 87 93.
33. Van Delden, C. Iglewski, B.H. (1998) Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 4, 551 560.